Clearmind Medicine acquires Charging Robotics stake
Analysis based on 9 articles · First reported Sep 04, 2026 · Last updated Sep 04, 2026
The acquisition is a small-scale diversification move for Clearmind Medicine, potentially broadening its business beyond biotech into EV infrastructure. The market impact is likely limited given the modest deal size, but it may generate some positive sentiment for Clearmind as it expands its portfolio.
Clearmind Medicine Inc., a clinical-stage biotech company, announced on September 4, 2026, that it has entered into a definitive agreement to acquire a 51% stake in Charging Robotics, a developer of intelligent wireless charging systems for automated parking and autonomous mobile platforms. The acquisition price is $2.5 million, and Clearmind will also extend a $1.5 million loan to Charging Robotics at 4% annual interest, due in three years with possible extension. The closing is expected during the week of September 7, 2026. This acquisition marks a strategic diversification for Clearmind, which focuses on psychedelic-based therapeutics, into the EV charging technology sector.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard